Enterprise Financial Services Corp Sage Therapeutics, Inc. Transaction History

Enterprise Financial Services Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $563 - $803	-14 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $817 - $1,246	14 New	14 $1,000
Q4 2018 Jan 25, 2019	SELL	$81.94 - $139.71 $1,311 - $2,235	-16 Closed	0 $0
Q3 2018 Oct 26, 2018	BUY	$138.11 - $169.04 $2,209 - $2,704	16 New	16 $2,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.